Skip to main content
Caplight Logo









enParticle

enParticle

Private
BusanHealthcare & Life Scienceshttps://enparticle.com

Last Round

Debt

Dec 1, 2022

Total Funding Raised

$5.63M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

enParticle operates in Healthcare & Life Sciences and is based in Busan. Its latest recorded funding round was a Debt round in December 2022.

enParticle is a drug delivery company that has developed a microfluidic formulation system designed for scalable and reproducible production of particles for the pharmaceutical, cosmetic, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

enParticle Comparables

Compare enParticle with similar companies based on industry and business-model similarity.

enParticle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PreciGenome
83%
Inside Therapeutics
77%
Danaher
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

enParticle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 1, 2022
Series AAug 1, 2022
StrategicApr 8, 2022
GrantJun 1, 2019
SeedApr 8, 2019
Seed
Feb 12, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

enParticle Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 56% MoM, reaching 2K.

  • Jun 21, 2026

    Monthly visitors grew 44% MoM, reaching 1.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

enParticle Filings

Explore SEC and related filing metadata, where available.

enParticle filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about enParticle's valuation, stock price, and market status.

Is enParticle a public or private company?

enParticle is a private company.

What is the current stock price of enParticle?

enParticle is a private company, so its shares have no public market price. Caplight tracks enParticle's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is enParticle worth (valuation)?

Valuation information for enParticle is not publicly available.

Can I buy enParticle stock?

enParticle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was enParticle's last funding round?

enParticle's most recent funding round was Debt on December 1, 2022.

Who are the main investors in enParticle?

Key investors in enParticle include KB Investment.

Will enParticle IPO soon?

No public IPO plans have been announced for enParticle.

How can I track enParticle secondary market activity?

Caplight tracks bids, offers, and trades in enParticle's shares on secondary markets.

Firmographic Details

HeadquartersBusan
Employee Range1
Year Founded2019
Last FundingDec 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?